Gene-based therapy for blindness?
The first clinical trial based on a promising new technology called RNA interference (RNAi) is set to begin in the US, to treat a progressive eye disorder. The researchers hope to test the safety of the technique for treating a disease called wet age-related macular degeneration (AMD). This condition, which...